Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

JNJ Press releases
Partner news

Period

2020
2019
2018
2017
2016
2015
(-) 2014
2013
2012
2011
2010
2009
2008

Jan
Feb
Mar
Apr
May
Jun
Jul
Sep
Oct
Nov
Dec

Locations & regions

Focus area

Clear filters

News

22 December 2014

MacroGenics Enters Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies

Read full story

18 December 2014

Padlock Therapeutics Secures $23 Million Series A Financing

Read full story

11 November 2014

La Lumiere Closes $20 Million Series B Financing

Read full story

7 November 2014

Four Health Care IPOs: Nevro

Read full story

JNJ Press releases

7 November 2014

Four Health Care IPOs: Nevro

Read full story

4 November 2014

Molecular Partners Has Successfully Priced its IPO Post Re-launch

Read full story

29 October 2014

Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson & Johnson Development Corporation

Read full story

JNJ Press releases

28 October 2014

Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances

Read full story

JNJ Press releases

22 October 2014

Johnson & Johnson Innovation Announces New J-Labs Incubator at Texas Medical Center

Read full story

16 October 2014

Tetra Discovery Partners Announces Additional Financing and Formation of Scientific Advisory Board

Read full story

Bavarian Nordic A/S: Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson & Johnson

Read full story

23 September 2014

Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment through Simple Blood Tests

Read full story

17 September 2014

Aratana Seeks more than $40M in Latest Public Stock Offering

Read full story

4 September 2014

Biocartis Raises EUR 64.5 Million plus EUR 15 Million for a New Spin-off

Read full story

Accelerator Opens an NYC hub with $51 Million in Backing from Pfizer, J&J, Lilly

Read full story

Load More

Sidebar

Currently trending

Currently trending

Cue Receives $481 Million Award by DOD and HHS to Expand Domestic Production Capacity and Provide 6 Million Molecular, Point-of-Care COVID-19 Tests
BaseLaunch announces that Johnson & Johnson Innovation has renewed its commitment becoming latest strategic partner in the second phase
Dr. Sadasivan Vidyasagar, Associate Professor at University of Florida, and entrinsic bioscience CEO Stephen Gatto, Receive University of Florida's 'Invention of the Year 2020' Award
XWPharma Announces $40 Million Financing and Appoints Leonard Blum as Chief Executive Officer
ESCAPE Bio Closes $73 Million in Crossover Financing to Advance Clinical Development of Precision Neurology Medicines for Genetic Neurodegeneration
Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease
Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration
Johnson & Johnson Innovation and Janssen Announce the Awardees of the World Without Disease Call-for-Proposal
GI Windows Raises $16.4M in Series A-1 Financing
Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases

Trending

Trending

Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, discusses the value of collaboration

Johnson & Johnson Innovation, Change One Thing, Change Everything: Medopad

Johnson & Johnson Innovation, Change One Thing, Change Everything: Exonate